Drugs / Measles and Rubella (MR)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05771779 | Oct 2023 → May 2025 | cholera, measles, rubella, typhoid fever | International Centre for Diarrhoeal Disease Research, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles and Rubella (MR) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05771779 ↗ |
| Modality | Vaccine | “MR vaccine for measles and rubella” NCT05771779 ↗ |